Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.46 - $5.92 $492,000 - $1.18 Million
-200,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.26 - $23.33 $1.28 Million - $7 Million
-300,000 Reduced 60.0%
200,000 $1.03 Million
Q3 2021

Nov 15, 2021

SELL
$18.12 - $28.5 $2.72 Million - $4.28 Million
-150,000 Reduced 23.08%
500,000 $12 Million
Q2 2021

Aug 16, 2021

SELL
$14.16 - $19.53 $4.96 Million - $6.84 Million
-350,000 Reduced 35.0%
650,000 $12.7 Million
Q1 2021

May 17, 2021

BUY
$15.9 - $18.61 $15.9 Million - $18.6 Million
1,000,000 New
1,000,000 $18.5 Million

Others Institutions Holding CNTB

About Connect Biopharma Holdings Ltd


  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $55.6M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.